We are developing a robust pipeline of drugs focused on oncology with multiple applications.

Pipeline

Our pipeline includes several novel clinical-stage drug candidates for cancer treatment and protection from lethal radiation.

CBLI Pipeline

Product Discovery Pre-clinical Pivotal Animal Studies Human Safety Studies
entolimod
 HP/GI Acute Radiation Syndrome
       
Product Discovery Pre-clinical Ph 1 Ph 2 Ph 3
CBL0137 ORAL FORMULATION
 Advanced Solid Tumors
         
CBL0137 I.V. FORMULATION
 Advanced Solid Tumors
         
entolimod
 Advanced Solid Tumors/Cancer Immunotherapy
         
CBL0102
 Hepatocellular Carcinoma
         
CBLB612
 Neutropenia/HST*
         
Discovery/Pre-clinical Programs
 
         

* HSCT means hematopoietic stem cell transplant

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue